.Merck defeats revenues requirements, increases purchases overview on tough need for top medicines like Keytruda CNBCMerck & Co. (MRK United States) Trumps Profit Forecasts as Keytruda Sales Increase BloombergMerck Supply: Pharma Giant Posts Solid Outcomes, Yet Overview Drops Short Capitalist's Business DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats income as well as purchases desires surrounded by Keytruda strong point, yet supplies mixed full-year expectation MarketWatch.